Anticancer potential of biogenic selenium nanoparticles from yeast and lactic acid bacteria: Advances, challenges, and opportunities

Key Points

• Biogenic selenium nanoparticles exhibit significant anticancer properties, with potential to reduce tumor growth.
• In vitro studies show up to 75% inhibition of cancer cell proliferation using these nanoparticles.
• Assessment of their effects involved functional assays and molecular profiling of the treated cells.
• The findings suggest the need for further studies to explore clinical applications and safety in human use.